Barth H, Berg P A, Klein R
Department of Internal Medicine II, University of Tübingen, Germany.
Clin Exp Immunol. 2003 Oct;134(1):78-85. doi: 10.1046/j.1365-2249.2003.02265.x.
In this study we performed several methods for the determination of cytokines (RT-PCR for the demonstration of cytokine mRNA and flow cytometry for the analysis of intracellular cytokines) and compared them with a recently established test system stimulating peripheral blood mononuclear cells (PBMC) with TH1- and TH2-relevant recall antigens and analysing type 1 and type 2 cytokines by ELISA. Aim of the study was therefore to evaluate the reliability of TH1/TH2 cytokine profiles in two individuals with different types of an allergic/atopic disposition: one of them showed a strong TH1/type 1-mediated tuberculin-reaction (subject A), the other (subject B) revealed elevated IgE-levels and eosinophil counts (TH2/type 2-mediated). PBMC were incubated with the type 1-antigen purified protein derivative (PPD) and the type 2-antigen tetanus-toxoid (TT) for seven days. From the comparison of ELISA with RT-PCR and flow cytometry-analysis it became evident that all three methods allowed the definition of subject A as a 'type 1-responder'. Subject B showed a pure type 2-response in the ELISA method; PCR and flow cytometry analysis revealed the simultaneous production of type 1- and type 2-cytokines resulting in a mixed type 1/type 2-profile. Active immunization of subject A with TT at the end of the observation period of 12 months resulted in a transient shift from type 1- to a mixed type 1/type 2-profile (simultaneous PPD-induced IFN-gamma- and TT-induced IL-5 production). From this pilot study based on clear cut clinical criteria concerning either a humoral or cellular immunological reactivity towards allergens/antigens it is suggested that the determination of type 1/type 2-cytokines by ELISA in supernatants of PBMC stimulated with type 1/type 2-relevant antigens is a useful approach for a better classification of 'type1-' or 'type 2-responder'.
在本研究中,我们采用了多种方法来测定细胞因子(用于检测细胞因子mRNA的逆转录聚合酶链反应和用于分析细胞内细胞因子的流式细胞术),并将它们与最近建立的一种检测系统进行比较,该系统用与TH1和TH2相关的回忆抗原刺激外周血单核细胞(PBMC),并用酶联免疫吸附测定法分析1型和2型细胞因子。因此,本研究的目的是评估两种具有不同类型过敏/特应性倾向个体中TH1/TH2细胞因子谱的可靠性:其中一人表现出强烈的TH1/1型介导的结核菌素反应(受试者A),另一人(受试者B)显示IgE水平和嗜酸性粒细胞计数升高(TH2/2型介导)。将PBMC与1型抗原纯化蛋白衍生物(PPD)和2型抗原破伤风类毒素(TT)孵育7天。通过酶联免疫吸附测定法与逆转录聚合酶链反应和流式细胞术分析的比较,很明显所有这三种方法都能将受试者A定义为“1型反应者”。受试者B在酶联免疫吸附测定法中表现出单纯的2型反应;聚合酶链反应和流式细胞术分析显示同时产生1型和2型细胞因子,从而形成混合的1/2型谱。在12个月的观察期结束时,用TT对受试者A进行主动免疫导致从1型暂时转变为混合的1/2型谱(同时有PPD诱导的干扰素-γ和TT诱导的白细胞介素-5产生)。基于关于对过敏原/抗原的体液或细胞免疫反应性的明确临床标准进行的这项初步研究表明,在用1/2型相关抗原刺激的PBMC上清液中通过酶联免疫吸附测定法测定1/2型细胞因子是更好地分类“1型反应者 ”或“2型反应者”的一种有用方法。